Author:
Qiu Ruijin,Zhao Chen,Liang Tengxiao,Hao Xuezeng,Huang Ya,Zhang Xiaoyu,Chen Zhao,Wei Xuxu,Zhao Mengzhu,Zhong Changming,Hu Jiayuan,Li Min,Han Songjie,He Tianmai,Sun Yang,Chen Jing,Shang Hongcai
Subject
Pharmacology (medical),Pharmacology
Reference12 articles.
1. HuangC.
A randomized, open-label, blank-controlled trial for the efficacy and safety of lopinavir-ritonavir and interferon-alpha 2b in hospitalization patients with novel coronavirus pneumonia (COVID-19)2020
2. Which trials registries are acceptable to the ICMJE?
3. The 2019 Novel Coronavirus Outbreak - A Global Threat;Khot;J. Assoc. Phys. India,2020
4. Core outcome set-standards for reporting: The COS-STAR Statement;Kirkham;PloS Med.,2016
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献